Mayne have reacted as wildly as any stock on the ASX over the last 6 months based in actuals.
$2 drop on FY because of flat Nextstellis and TxD sales, and a disappointing Derm result.
Now a solid $2.20 gain on a set of numbers at the 1/4 that supported the commentary at the FY.
Just shows that the market isn't blind, positively deliver what you are promising; and make good decisions (Finally the BB we all wanted, Stop the unaccountable S&M spend, reduce overheads, expand products without throwing good money after bad), and the Market reacts in your favor.
Expecting a polished display from our CEO tomorrow, and given that, if guidance is in line with 1/4 results, we should only have blue skies for a while.
Just won't want to be hearing any issues with Derm.(as $6m+ so massively important), or that the stunning (compared to flat 2nd 1/2) sales results from Nextstellis was a result of a 'special event' and they have flattened. Would also be great to hear some of the progress towards slicing $10m in overheads and also an update on legal action as the $'s are building there and still a fair ? over out head.
Enjoy the run. DB
MYX Price at posting:
$5.18 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)